Advanced search
Publication Cover
HIV Clinical Trials Volume 19, 2018 - Issue 4
Submit an article Journal homepage
4,382
Views
47
CrossRef citations to date
0
Altmetric
Original Articles

Satisfaction and acceptability of cabotegravir long-acting injectable suspension for prevention of HIV: Patient perspectives from the ECLAIR trial

Miranda I. MurrayViiV Healthcare, London, UK; Correspondence[email protected]
View further author information
,
Martin MarkowitzThe Aaron Diamond AIDS Research Center, an affiliate of the Rockefeller University, New York, NY, USA; View further author information
,
Ian FrankPerelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; View further author information
,
Robert M. GrantInstitute of Virology and Immunology, Gladstone Institutes, San Francisco, CA, USA; ;Department of Medicine, University of California, San Francisco, CA, USA; View further author information
,
Kenneth H. MayerThe Fenway Institute, Fenway Health, Boston, MA, USA; ;Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA; ORCID Iconhttp://orcid.org/0000-0001-7460-733XView further author information
ORCID Icon,
Krischan J. HudsonViiV Healthcare, Research Triangle Park, NC, USA; View further author information
,
Britt S. StancilPAREXEL International, Durham, NC, USA; View further author information
,
Susan L. FordGlaxoSmithKline, Research Triangle Park, NC, USAView further author information
,
Parul PatelViiV Healthcare, Research Triangle Park, NC, USA; View further author information
,
Alex R. RinehartViiV Healthcare, Research Triangle Park, NC, USA; View further author information
,
William R. SpreenViiV Healthcare, Research Triangle Park, NC, USA; View further author information
&
David A. MargolisViiV Healthcare, Research Triangle Park, NC, USA; View further author information
 show all
Pages 129-138 | Received 23 May 2018, Accepted 05 Aug 2018, Published online: 16 Nov 2018

Related Research Data

Satisfaction and acceptability of cabotegravir long-acting injectable suspension for prevention of HIV: Patient perspectives from the ECLAIR trial
Source: Figshare
Satisfaction and acceptability of cabotegravir long-acting injectable suspension for prevention of HIV: Patient perspectives from the ECLAIR trial
Source: Figshare

Linking provided by 

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.